Latest News
Aurora Cannabis Closes Acquisition of US-based Hemp-Derived CBD Products Firm Reliva
Friday 29 May 2020

Canada-based cannabinoids company Aurora Cannabis Inc (NYSE: ACB) (TSX: ACB) has completed the previously announced acquisition of US-based hemp-derived CBD products producer Reliva, LLC for approximately USD 40m of Aurora common shares, the company said.

The transaction also includes a potential earn-out of up to a maximum of USD 45m payable at Aurora's option in shares or cash contingent upon Reliva achieving certain financial targets over the next two years.

Aurora is in the cannabis industry serving both the medical and consumer markets.

Headquartered in Edmonton, Alberta, Aurora's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports.

Providing customers with cannabis products, Aurora's brands are in the medical, performance, wellness and recreational markets.

Reliva is in delivering high quality hemp-derived CBD products to consumers.

Built on a philosophy of compliance, testing, product innovation and approachable price points

Reliva has grown to become one of the largest retail CBD brands in the US Supported through long-term partnerships with national wholesalers and retailers Reliva's products can be found in over 20,000 retail stores.

Reliva's products contain CBD derived from industrial hemp in compliance with the US Agriculture Improvement Act of 2018 (2018 Farm Bill), and its products are not subject to the US Controlled Substances Act.
Details
Date Published: 29/05/2020

Options